[H-3]2-(2-benzofuranyl)-2-imidazoline: A new selective high affinity radioligand for the study of rabbit brain imidazoline I-2 receptors

被引:51
作者
Lione, LA [1 ]
Nutt, DJ [1 ]
Hudson, AL [1 ]
机构
[1] UNIV BRISTOL,SCH MED SCI,DEPT PHARMACOL,PSYCHOPHARMACOL UNIT,BRISTOL BS8 1TD,AVON,ENGLAND
基金
英国医学研究理事会;
关键词
imidazoline I-2 receptor; H-3]2-(2-benzofuranyl)-2-imidazoline; idazoxan; clonidine;
D O I
10.1016/0014-2999(96)00131-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This is the first study characterising the binding of the new imidazoline I-2 receptor selective radioligand [H-3]2-(2-benzofuranyl)-2-imidazoline (2-BFI) to rabbit brain membranes. [H-3]2-BFI binding was found to be saturable and of high affinity identifying two binding sites with K-D1 = 0.27 nM, B-max = 111.2 fmol mg(-1) protein and K-D2 = 8.97 nM, B-max = 268 fmol mg(-1) protein. Specific binding represented greater than 90% of total binding. Kinetic studies revealed that the binding was rapid and reversible and also showed [H-3]2-BFI interacted with these two sites or two affinity states. In competition binding studies against [H-3]2-BFI (0.3-lnM) idazoxan, 2-BFI, cirazoline, guanabenz, naphazoline, amiloride and BU224 (2-(4,5-dihydroimidaz-2-yl-quinoline) displaced with high affinity. In contrast the alpha(2)-adrenoceptor antagonists efaroxan and rauwolscine, the I-1 site selective drug moxonidine, the monoamine oxidase-A inhibitor clorgyline and the proposed endogenous imidazoline receptor ligand, agmatine, were weak at displacing [H-3]2-BFI binding. These findings are consistent with [H-3]2-BFI recognising imidazoline receptors of the I-2 subtype in rabbit brain.
引用
收藏
页码:221 / 229
页数:9
相关论文
共 48 条
[1]   THE EFFECTS OF PHENELZINE AND OTHER MONOAMINE-OXIDASE INHIBITOR ANTIDEPRESSANTS ON BRAIN AND LIVER I-2 IMIDAZOLINE-PREFERRING RECEPTORS [J].
ALEMANY, R ;
OLMOS, G ;
GARCIASEVILLA, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (04) :837-845
[2]  
ALEMANY R, 1995, BRIT J PHARMACOL, V116, pP135
[3]   IDENTIFYING CLONIDINE-DISPLACING SUBSTANCE [J].
ATLAS, D .
SCIENCE, 1994, 266 (5184) :462-463
[4]  
BOYAJIAN CL, 1987, J PHARMACOL EXP THER, V241, P1079
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   THE IMIDAZOLINE PREFERRING RECEPTOR - BINDING-STUDIES IN BOVINE, RAT AND HUMAN BRAIN-STEM [J].
BRICCA, G ;
DONTENWILL, M ;
MOLINES, A ;
FELDMAN, J ;
BELCOURT, A ;
BOUSQUET, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (01) :1-9
[7]   STIMULATION OF INSULIN-SECRETION BY IMIDAZOLINE COMPOUNDS IS NOT DUE TO INTERACTION WITH NON-ADRENOCEPTOR IDAZOXAN BINDING-SITES [J].
BROWN, CA ;
LOWETH, AC ;
SMITH, SA ;
MORGAN, NG .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) :312-317
[8]   ALPHA-2-ADRENOCEPTOR SUBTYPES AND IMIDAZOLINE-LIKE BINDING-SITES IN THE RAT-BRAIN [J].
BROWN, CM ;
MACKINNON, AC ;
MCGRATH, JC ;
SPEDDING, M ;
KILPATRICK, AT .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (04) :803-809
[9]  
CARPENE C, 1995, J PHARMACOL EXP THER, V272, P681
[10]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099